WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Oncogene

• Publication date

  2013-03-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/onc.2012.153PMID 22641220
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma

  2012cited by this paper
• Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor.

  2012cited by this paper
• Initial testing of the investigational NEDD8‐activating enzyme inhibitor MLN4924 by the pediatric preclinical testing program

  2012cited by this paper
• Quantitative Proteomic Analysis of Cellular Protein Modulation upon Inhibition of the NEDD8-Activating Enzyme by MLN4924

  2011cited by this paper
• Induction of p21-dependent senescence by an NAE inhibitor, MLN4924, as a mechanism of growth suppression.

  2011cited by this paper
• Inhibition of NEDD8-activating enzyme induces rereplication and apoptosis in human tumor cells consistent with deregulating CDT1 turnover.

  2011cited by this paper
• Systematic and quantitative assessment of the ubiquitin-modified proteome.

  2011cited by this paper
• The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES)

  2010cited by this paper
• In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma.

  2010cited by this paper
• Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia.

  2010cited by this paper
• Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics.

  2010cited by this paper
• NEDD8-targeting drug MLN4924 elicits DNA rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells.

  2010cited by this paper
• Molecular characterization of commonly used cell lines for bone tumor research: A trans‐European EuroBoNet effort

  2010cited by this paper
• MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphoma.

  2010cited by this paper
• Acetylation by GCN5 regulates CDC6 phosphorylation in the S phase of the cell cycle

  2009cited by this paper
• An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer

  2009cited by this paper
• Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation.

  2008cited by this paper
• Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer

  2008cited by this paper
• Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases.

  2007cited by this paper
• Multiple Mechanisms for p27Kip1 Translocation and Degradation

  2007cited by this paper
• p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2.

  2007cited by this paper
• Ewing's sarcoma family of tumors: current management.

  2006cited by this paper
• Adaptation to the ionizing radiation-induced G2 checkpoint occurs in human cells and depends on checkpoint kinase 1 and Polo-like kinase 1 kinases.

  2006cited by this paper
• Two E3 ubiquitin ligases, SCF‐Skp2 and DDB1‐Cul4, target human Cdt1 for proteolysis

  2006cited by this paper
• M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP.

  2004cited by this paper
• Skp2-mediated degradation of p27 regulates progression into mitosis.

  2004cited by this paper
• The SCF ubiquitin ligase: insights into a molecular machine

  2004cited by this paper
• Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage

  2003cited by this paper
• Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage.

  2003cited by this paper
• Chk1 and Chk2 kinases in checkpoint control and cancer.

  2003cited by this paper
• Phosphorylation of mammalian CDC6 by Cyclin A/CDK2 regulates its subcellular localization

  1999cited by this paper
• Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of I kappa B alpha.

  1999cited by this paper
• Recruitment of a ROC1–CUL1 Ubiquitin Ligase by Skp1 and HOS to Catalyze the Ubiquitination of IκBα

  1999cited by this paper
• Multistep regulation of DNA replication by Cdk phosphorylation of HsCdc6.

  1999cited by this paper
• SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27

  1999cited by this paper
• p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27.

  1999cited by this paper
• CDC25A Phosphatase Is a Target of E2F and Is Required for Efficient E2F-Induced S Phase

  1999cited by this paper
• Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells.

  1999cited by this paper
• Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins.

  1998cited by this paper
• Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex

  1996cited by this paper
• Regulation of the human WEE1Hu CDK tyrosine 15‐kinase during the cell cycle.

  1995cited by this paper
• Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15.

  1993cited by this paper

• Pevonedistat targeting NEDDylation activating enzyme for human diseases: Underlying mechanisms, clinical studies, and future directions.

  2026cites this paper
• Druggable upregulated proteins in EWS-FLI-driven Ewing sarcoma as emerging new therapeutic targets.

  2025cites this paper
• VOPP1, a Determinant of the Sensitivity of Non-Small Cell Lung Cancer Cells to NAE Inhibitors.

  2025cites this paper
• Targeting autophagy and metabolism for ewing sarcoma

  2025cites this paper
• Fbxo2 inhibits cell proliferation, migration and invasion by the ubiquitin-mediated degradation of WEE1 in renal cell carcinoma

  2025cites this paper
• MLN4924, neddylation inhibitor suppresses hypoxia induced retinal angiogenesis by targeting Human Antigen R signaling.

  2025cites this paper
• Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615).

  2024cites this paper
• Inhibiting neddylation: A new strategy for tumor therapy

  2024cites this paper
• Protein neddylation and its role in health and diseases

  2024cites this paper
• Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy

  2023cites this paper
• Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions

  2023cites this paper
• Neddylation inactivation affects cell cycle and apoptosis in sheep follicular granulosa cells

  2022cites this paper
• An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma

  2022cites this paper
• NEDD8-activating enzyme inhibition induces cell cycle arrest and anaphase catastrophe in malignant T-cells

  2021cites this paper
• E1 Enzymes as Therapeutic Targets in Cancer

  2021cites this paper
• Targeting neddylation E2s: a novel therapeutic strategy in cancer

  2021cites this paper
• The Absence of PTEN in Breast Cancer Is a Driver of MLN4924 Resistance

  2021cites this paper
• The Anti-Tumor Activity of the NEDD8 Inhibitor Pevonedistat in Neuroblastoma

  2021influential citation
• Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumors.

  2021cites this paper
• The pivotal roles of neddylation pathway in immunoregulation

  2020cites this paper
• Neddylation: A Versatile Pathway Takes on Chronic Liver Diseases

  2020cites this paper
• Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials

  2020cites this paper
• The NEDD8-activating enzyme inhibition with MLN4924 sensitizes human cancer cells of different origins to apoptosis and necroptosis.

  2020cites this paper
• KONAKLAMA SEKTÖRÜNDE DİZGİNLEYİCİ KÜLTÜRÜN DUYGUSAL EMEK VE KÜLTÜREL DUYARLILIK İLİŞKİSİ ÜZERİNDEKİ ETKİSİ

  2019cites this paper
• TAS4464, A Highly Potent and Selective Inhibitor of NEDD8-Activating Enzyme, Suppresses Neddylation and Shows Antitumor Activity in Diverse Cancer Models

  2019cites this paper
• Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer

  2019cites this paper
• SCFFBXO28-mediated self-ubiquitination of FBXO28 promotes its degradation.

  2019cites this paper
• Wee1 kinase inhibitor MK-1775 induces apoptosis of acute lymphoblastic leukemia cells and enhances the efficacy of doxorubicin involving downregulation of Notch pathway.

  2018cites this paper
• Protein neddylation and its alterations in human cancers for targeted therapy.

  2018cites this paper
• Chk1 inhibitor SCH 900776 enhances the antitumor activity of MLN4924 on pancreatic cancer

  2018cites this paper
• Inhibition of neddylation pathway represses influenza virus replication and pro-inflammatory responses.

  2018cites this paper
• Inhibition of neddylation facilitates cell migration through enhanced phosphorylation of caveolin-1 in PC3 and U373MG cells

  2018cites this paper
• The Nedd8‐activating enzyme inhibitor MLN4924 (TAK‐924/Pevonedistat) induces apoptosis via c‐Myc‐Noxa axis in head and neck squamous cell carcinoma

  2018cites this paper
• MRFAP1 plays a protective role in neddylation inhibitor MLN4924-mediated gastric cancer cell death.

  2018cites this paper
• MLN4924 (Pevonedistat), a protein neddylation inhibitor, suppresses proliferation and migration of human clear cell renal cell carcinoma

  2017cites this paper
• Targeting the protein ubiquitination machinery in melanoma by the NEDD8-activating enzyme inhibitor pevonedistat (MLN4924)

  2017cites this paper
• Targeting neddylation pathway with MLN4924 (Pevonedistat) induces NOXA-dependent apoptosis in renal cell carcinoma.

  2017cites this paper
• MLN4924 neddylation inhibitor promotes cell death in paclitaxel-resistant human lung adenocarcinoma cells.

  2017cites this paper
• Targeting NEDD8 Conjugation for Therapeutic Gain in Acute Lymphoblastic Leukemia

  2017cites this paper
• The fate of murine double minute X (MdmX) is dictated by distinct signaling pathways through murine double minute 2 (Mdm2)

  2017cites this paper
• COPS5 inhibition arrests the proliferation and growth of serous ovarian cancer cells via the elevation of p27 level.

  2017cites this paper
• Inhibition of Mcl‐1 enhances Pevonedistat‐triggered apoptosis in osteosarcoma cells

  2017cites this paper
• MLN4924 therapy as a novel approach in cancer treatment modalities

  2016cites this paper
• Distinct outcomes of CRL–Nedd8 pathway inhibition reveal cancer cell plasticity

  2016cites this paper
• Process Development and GMP Production of a Potent NEDD8-Activating Enzyme (NAE) Inhibitor: Pevonedistat

  2016cites this paper
• The roles and therapeutic potential of cyclin-dependent kinases (CDKs) in sarcoma

  2016cites this paper
• Cullin 5-RING E3 ubiquitin ligases, new therapeutic targets?

  2016cites this paper
• MLN4924 suppresses neddylation and induces cell cycle arrest, senescence, and apoptosis in human osteosarcoma

  2016cites this paper
• Suppression of glioblastoma by targeting the overactivated protein neddylation pathway.

  2015cites this paper
• Molecular Genetics of Ewing Sarcoma

  2015cites this paper
• Process Development and GMP Production of a Potent NAE Inhibitor Pevonedistat

  2015cites this paper
• High Efficiency Apoptosis Induction in Breast Cancer Cell Lines by MLN4924/2DG Co-Treatment.

  2015cites this paper
• Targeting cullin-RING ligases for cancer treatment: rationales, advances and therapeutic implications

  2015influential citation
• Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells

  2015cites this paper
• Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid Tumors

  2015cites this paper
• AnnexinV-Fluorescein Isothiocyanate and PI Staining and Fluorescence-activated Cell Sorting Analysis

  2015cites this paper
• Targeting neddylation induces DNA damage and checkpoint activation and sensitizes chronic lymphocytic leukemia B cells to alkylating agents

  2015cites this paper
• The Role of the COP9 Signalosome and Neddylation in DNA Damage Signaling and Repair

  2015influential citation
• Neddylation Pathway as a Novel Anti-cancer Target: Mechanistic Investigation and Therapeutic Implication.

  2015cites this paper
• Overactivated neddylation pathway as a therapeutic target in lung cancer.

  2014cites this paper
• SCF ubiquitin ligase-targeted therapies

  2014cites this paper
• Innovative Therapies in Ewing Sarcoma

  2014cites this paper
• Neddylation pathway is up-regulated in human intrahepatic cholangiocarcinoma and serves as a potential therapeutic target

  2014cites this paper
• Suppression of tumor angiogenesis by targeting the protein neddylation pathway

  2014cites this paper
• Targeting the Neddylation Pathway to Suppress the Growth of Prostate Cancer Cells: Therapeutic Implication for the Men's Cancer

  2014cites this paper
• The Neddylation-Cullin 2-RBX1 E3 Ligase Axis Targets Tumor Suppressor RhoB for Degradation in Liver Cancer*

  2014cites this paper
• Targeting Neddylation Pathways to Inactivate Cullin-RING Ligases for Anticancer Therapy

  2014cites this paper
• Senescence bypass in mesenchymal stem cells: a potential pathogenesis and implications of pro-senescence therapy in sarcomas

  2013cites this paper
• When ubiquitin meets NF-κB: a trove for anti-cancer drug development.

  2013cites this paper
• Systems biology of Ewing sarcoma: a network model of EWS-FLI1 effect on proliferation and apoptosis

  2013cites this paper
• Growth-Promoting Role of the miR-106a∼363 Cluster in Ewing Sarcoma

  2013cites this paper